Pacylex Pharmaceuticals Publishes a New Myristoylation Inhibitor Mechanism of Anti-Cancer Activity in Molecular Cancer Therapeutics ...
The regulation and remodeling of the tumor microenvironment (TME) are closely associated with how cancers typically progress ...
AstraZeneca and Daiichi Sankyo announced that their drug Enhertu (trastuzumab deruxtecan) has been granted Priority Review by the US FDA for trea ...
As Roche comes under competitive pressure on its breast cancer business, the Swiss company hopes a new drug will add a ...
immunogen = GST-fusion protein corresponding to residues 1-149 of human Akt ...
They investigated whether allografts are sensitive to immune checkpoint blockade (ICB) using antibodies against programmed ...
AstraZeneca's pan-AKT kinase inhibitor for breast cancer, which has shown efficacy in patients with hormone receptor positive, HER2-negative advanced breast cancer – regardless of their PIK3CA ...
There are similar data with EGFR monoclonal antibodies. Unlike in lung cancer ... PTEN = phosphatase and tension homolog deleted on chromosome 10; AKT = protein kinase B; STAT = signal transducer ...
No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).